154 related articles for article (PubMed ID: 34437914)
1. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
[TBL] [Abstract][Full Text] [Related]
2. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
[TBL] [Abstract][Full Text] [Related]
3. Laser-assisted nanocarrier delivery to achieve cutaneous siRNA targeting for attenuating psoriasiform dermatitis.
Lee WR; Chou WL; Lin ZC; Sung CT; Lin CY; Fang JY
J Control Release; 2022 Jul; 347():590-606. PubMed ID: 35623494
[TBL] [Abstract][Full Text] [Related]
4. Small interfering RNA targeting of keratin 17 reduces inflammation in imiquimod-induced psoriasis-like dermatitis.
Xiao CY; Zhu ZL; Zhang C; Fu M; Qiao HJ; Wang G; Dang EL
Chin Med J (Engl); 2020 Nov; 133(24):2910-2918. PubMed ID: 33237695
[TBL] [Abstract][Full Text] [Related]
5. Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis.
Nemati H; Ghahramani MH; Faridi-Majidi R; Izadi B; Bahrami G; Madani SH; Tavoosidana G
J Control Release; 2017 Dec; 268():259-268. PubMed ID: 29074408
[TBL] [Abstract][Full Text] [Related]
6. Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques.
Marepally S; Boakye CH; Patel AR; Godugu C; Doddapaneni R; Desai PR; Singh M
Nanomedicine (Lond); 2014 Jul; 9(14):2157-74. PubMed ID: 24593003
[TBL] [Abstract][Full Text] [Related]
7. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
[TBL] [Abstract][Full Text] [Related]
8. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
[TBL] [Abstract][Full Text] [Related]
9. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions.
Rahmanian-Devin P; Askari VR; Sanei-Far Z; Baradaran Rahimi V; Kamali H; Jaafari MR; Golmohammadzadeh S
Biomed Pharmacother; 2023 Dec; 168():115823. PubMed ID: 37924792
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer as a new potential carrier for topical delivery of siRNA: A comparative study of dendriplex vs. lipoplex for delivery of TNF-α siRNA.
Pandi P; Jain A; Kommineni N; Ionov M; Bryszewska M; Khan W
Int J Pharm; 2018 Oct; 550(1-2):240-250. PubMed ID: 30165098
[TBL] [Abstract][Full Text] [Related]
12. Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment.
Boakye CHA; Patel K; Doddapaneni R; Bagde A; Marepally S; Singh M
J Control Release; 2017 Jan; 246():120-132. PubMed ID: 27170227
[TBL] [Abstract][Full Text] [Related]
13. Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Pukale SS; Sharma S; Dalela M; Singh AK; Mohanty S; Mittal A; Chitkara D
Acta Biomater; 2020 Oct; 115():393-409. PubMed ID: 32846238
[TBL] [Abstract][Full Text] [Related]
14. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
[TBL] [Abstract][Full Text] [Related]
15. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
16. Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.
Desai PR; Marepally S; Patel AR; Voshavar C; Chaudhuri A; Singh M
J Control Release; 2013 Aug; 170(1):51-63. PubMed ID: 23643662
[TBL] [Abstract][Full Text] [Related]
17. Solid Lipid-Polymer Hybrid Nanoplatform for Topical Delivery of siRNA: In Vitro Biological Activity and Permeation Studies.
de Araujo MM; Borgheti-Cardoso LN; Praça FG; Marcato PD; Bentley MVLB
J Funct Biomater; 2023 Jul; 14(7):. PubMed ID: 37504869
[TBL] [Abstract][Full Text] [Related]
18. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-loaded lipid-hybridized cellulose nanofiber film ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Kang NW; Kim MH; Sohn SY; Kim KT; Park JH; Lee SY; Lee JY; Kim DD
Biomaterials; 2018 Nov; 182():245-258. PubMed ID: 30142524
[TBL] [Abstract][Full Text] [Related]
20. Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.
Sun L; Liu Z; Wang L; Cun D; Tong HHY; Yan R; Chen X; Wang R; Zheng Y
J Control Release; 2017 May; 254():44-54. PubMed ID: 28344018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
